<?xml version="1.0" encoding="UTF-8"?>
<ref id="b8-1040138">
 <label>8.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Houot</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Le Gouill</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Ojeda Uribe</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS</article-title>. 
  <source>Ann Oncol</source>. 
  <year>2012</year>;
  <volume>23</volume>(
  <issue>6</issue>):
  <fpage>1555</fpage>â€“
  <lpage>1561</lpage>.
  <pub-id pub-id-type="pmid">22012966</pub-id>
 </mixed-citation>
</ref>
